Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Oct;50(4):493–499. doi: 10.1038/bjc.1984.206

Quantitative aspects of the E2 receptor assay for human breast tumour cytosol using dextran-coated charcoal.

D W Wilson, G Richards, R I Nicholson, K Griffiths
PMCID: PMC1976907  PMID: 6207852

Abstract

Misclassification of the oestrogen status of a human breast tumour cytosol, arising from different sources and magnitudes of error in the dextran-coated charcoal (DCC) method, have been investigated using both practical and computer simulated data analysed by Scatchard and Mass Action models. The minimum detectable receptor site concentration, relative or absolute numerical bias and imprecision which are complex and integral functions of misclassification, have been calculated from practical data and for a range of experimental conditions likely to be encountered in practice. The Mass Action model was found to be superior and the computer program, designed to investigate the effects of methodological errors on quantitative aspects of the assay, may be a useful aid for analytical design and internal quality control of the receptor assay.

Full text

PDF
493

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  2. Chamness G. C., McGuire W. L. Scatchard plots: common errors in correction and interpretation. Steroids. 1975 Oct;26(4):538–542. doi: 10.1016/0039-128x(75)90073-2. [DOI] [PubMed] [Google Scholar]
  3. Haybittle J. L., Blamey R. W., Elston C. W., Johnson J., Doyle P. J., Campbell F. C., Nicholson R. I., Griffiths K. A prognostic index in primary breast cancer. Br J Cancer. 1982 Mar;45(3):361–366. doi: 10.1038/bjc.1982.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jensen E. V., Smith S., DeSombre E. R. Hormone dependency in breast cancer. J Steroid Biochem. 1976 Nov-Dec;7(11-12):911–917. doi: 10.1016/0022-4731(76)90010-8. [DOI] [PubMed] [Google Scholar]
  5. McGuire W. L., Horwitz K. B., Pearson O. H., Segaloff A. Current status of estrogen and progesterone receptors in breast cancer. Cancer. 1977 Jun;39(6 Suppl):2934–2947. doi: 10.1002/1097-0142(197706)39:6<2934::aid-cncr2820390680>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  6. Nicholson R. I., Campbell F. C., Blamey R. W., Elston C. W., George D., Griffiths K. Steroid receptors in early breast cancer: value in prognosis. J Steroid Biochem. 1981 Dec;15:193–199. doi: 10.1016/0022-4731(81)90275-2. [DOI] [PubMed] [Google Scholar]
  7. Richards G., Wilson D. W., Griffiths K. Computer-aided assessment of receptor status in human breast cancer. Comput Biomed Res. 1983 Oct;16(5):483–498. doi: 10.1016/0010-4809(83)90036-8. [DOI] [PubMed] [Google Scholar]
  8. Wilson D., Sarfaty G., Clarris B., Douglas M., Crawshaw K. The prediction of standard curves and errors for the assay of estradiol by competitive protein binding. Steroids. 1971 Jul;18(1):77–90. doi: 10.1016/s0039-128x(71)80173-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES